Back to BAKER BROS. ADVISORS LP

CRNX
7 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in CRINETICS PHARMACEUTICALS IN

BAKER BROS. ADVISORS LP holds 2.4M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $85.4M as of 2026-Q1. The position was increased (+42.6% shares). CRNX represents 0.5% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$85.4M

Current Shares

2.4M

Total Value Change

+$80.8M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.4M
+42.6%
$85.4M0.5%$40.12
48
2025-Q4
Increased
1.6M
+488.9%
$76.8M0.4%$47.39
57
2025-Q3
Unchanged
280,000
0.0%
$11.7M0.1%$43.51
0
2025-Q2
New
280,000
-
$8.1M0.1%$29.96
38
2024-Q4
Exited
0
-100.0%
$00.0%$50.67
0
2024-Q3
Unchanged
103,927
0.0%
$5.3M0.1%$50.75
0
2024-Q2
New
103,927
-
$4.7M0.1%$44.79
37

Other major holders of CRNX: FMR LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used